Overview

Effect of Uridine on GABA and High Energy Phosphate Levels in Healthy Volunteers

Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
On the dual basis of findings indicating GABA increases following acute and eight week SSRI/dopamine agonist administration and those indicating GABA-ergic effects following 14 day pyrimidine administration, the purpose of this study is to assess our following hypotheses: 1. Relative to placebo, an oral dose of 1g of uridine BID for seven days will increase brain GABA levels in a sample of healthy, unmedicated adult males; 2. Relative to placebo, an oral dose of 1g of uridine BID for seven days will increase NTP levels in a sample of healthy, unmedicated adult males; and 3. Brain GABA levels will be directly correlated to high energy phosphate levels in this sample of healthy, unmedicated adult males.
Phase:
Phase 1
Details
Lead Sponsor:
Mclean Hospital
Collaborator:
National Institute of Mental Health (NIMH)